Semaglutide

$0.00

An FDA-approved GLP-1 receptor agonist that improves glucose control and, in appropriate patients, supports substantial weight loss and reduces certain cardiovascular risks.

An FDA-approved GLP-1 receptor agonist that improves glucose control and, in appropriate patients, supports substantial weight loss and reduces certain cardiovascular risks.